Antisense Therapeutics Limited advised that Non-Executive Director of the Company, Dr. Gary Pace, has confirmed his intention to retire this year from the Board of Directors. After seven years as a director, Dr Pace was due to stand for re- election at the upcoming 2022 Annual General Meeting of shareholders and accordingly will not seek re-election. As a result of this decision, Dr Pace will retire from the Board at the conclusion of the 2022 Annual General Meeting, scheduled for 17 November 2022.

Dr. Pace has served the Company as a Non-Executive Director since 2015 and is currently Governance and Nomination Chair, Remuneration Committee Member, Audit & Risk Committee Member.